Articles
CRN: Goldilocks and the regulatory bear: Avoiding the too-hot, too-cold pitfalls of supplement rules
Dec 11, 2024 |
nutraingredients-usa.com | Steve Mister |Stephen Daniells |Danielle Masterson |Nutrasource Pharmaceutical
As 2024 comes to a close, and I consider the events of the year, it feels a little like a Goldilocks moment, “This regulation is too hot; this one is too cold; and this one is just right.” Thirty years after the passage of DSHEA, the foundational law that set the robust dietary supplement engine into motion, industry stakeholders are still trying to balance consumer access and consumer safety just right.
-
Sep 9, 2024 |
supplysidesj.com | Steve Mister
CRN's Steve Mister discusses the retraction of a controversial 2013 DNA study that led to a significant investigation of the dietary supplement industry by the New York Attorney General in 2015. The piece reflects on the implications of the retraction for the industry and emphasizes the importance of scientific integrity and proactive regulation. It also highlights the industry's efforts to rebuild trust and the ongoing need for vigilance against future crises.
-
Sep 9, 2024 |
supplysidesj.com | Steve Mister
Steve Mister of the Council for Responsible Nutrition examines a controversial "drug preclusion" provision in DSHEA, an anticipated FDA rulemaking for NAC and possible legislative changes to protect the supplement industry. At a GlanceThe end of Chevron deference doesn’t change the fact that FDA's interpretation of drug preclusion is flawed. FDA’s hesitancy and enforcement discretion on NAC reveal the agency’s insecurity in its drug preclusion stance.
-
Sep 4, 2024 |
naturalproductsinsider.com | Lisa Schofield |Larisa Pavlick |Karin VanSlyke |Steve Mister
IMMUSE, the first postbiotic supplement to activate the complete immune system, resonates with the whole-system approach women seek. The story about how the Covid-19 pandemic changed the world is still being written. However, one outcome is certain: The way people approach their personal health and wellness will never quite be the same again, particularly when it comes to protecting their immune systems.
-
Sep 3, 2024 |
naturalproductsinsider.com | Larisa Pavlick |Karin VanSlyke |Steve Mister
First identified in 1954, alpha yohimbine is a botanical ingredient from the bark of the Central African yohimbe tree (Pausinystalia yohimbe). CHERESO embarked on a mission to unlock the full potential of this extraordinary compound in 2008. A team of scientists and experts devoted nearly seven years to the meticulous process of isolation and production and in 2015 produced the first commercial batch of alpha yohimbine.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →